Funded Tech Companies
Remedy Plan Therapeutics
Wondering who provided funding to Remedy Plan Therapeutics? Alexandria Venture Investments, Schooner Capital and private investors put venture money into this healthcare services company.
Company Overview
Company Name
Remedy Plan Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Gaithersburg, MD Undisclosed
USA
Gaithersburg, MD Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
All human cells require energy (e.g., sugar and fat) to function and survive, and the NAMPT enzyme controls how cells use energy. Well-regulated NAMPT activity is paramount to human health, with thousands of research articles connecting NAMPT dysregulation to more than 20 distinct diseases, spanning oncology, autoimmune and metabolic disorders. To treat these numerous diseases, many Pharma companies tried to make NAMPT-targeting drugs; however, they all caused significant on-target toxicity and none have advanced beyond Phase 2 clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/13/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Greg Crimmins
Company Investors
- Alexandria Venture Investments
- Schooner Capital
Browse more funded tech companies:
Remedy Pharmaceuticals | Remedy Review
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs